Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IDECABTAGENE VICLEUCEL vs IMDEVIMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

IDECABTAGENE VICLEUCEL vs IMDEVIMAB: Safety Overview

Metric IDECABTAGENE VICLEUCEL IMDEVIMAB
Total FAERS Reports 1,037 432
Deaths Reported 137 24
Death Rate 13.2% 5.6%
Hospitalizations 356 202
Average Patient Age 65.3 yrs 56.2 yrs
% Female Patients 41.9% 52.7%
Manufacturer Celgene Corporation N/A
Route INTRAVENOUS N/A